Started doing my DD. Anybody here following it? Synthetic Biologics. They will have Phase II results in 1H 2014 for Trimesta, an oral formulation of estriol for the treatment of relapsing-remitting multiple sclerosis.
And they have SYN-004 for the prevention of clostridium difficile (C. difficile or C. diff) infections. But this one is still in early stages.
It looks attractive to me, the only problem that I see is they are running out of cash (I guess 2H 2014) so probably dilution soon coming.